Gene · 7980
Papers2,421
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,421
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The utility of a methylation panel in the assessment of clinical response to radiofrequency ablation for Barrett's esophagus. | EBioMedicine | 2020 | 32707444 | PubTator, text mining | PubMed |
| Reanalysis of Genomic Sequencing Results in a Clinical Laboratory: Advantages and Limitations. | Front Neurol | 2020 | 32695065 | PubTator, text mining | PubMed |
| Alternative methylation of intron motifs is associated with cancer-related gene expression in both canine mammary tumor and human breast cancer. | Clin Epigenetics | 2020 | 32693820 | PubTator, text mining | PubMed |
| The emerging role of fibroblast-like synoviocytes-mediated synovitis in osteoarthritis: An update. | J Cell Mol Med | 2020 | 32686306 | PubTator, text mining | PubMed |
| Combined signaling of NF-kappaB and IL-17 contributes to Mesenchymal stem cells-mediated protection for Paraquat-induced acute lung injury. | BMC Pulm Med | 2020 | 32680482 | PubTator, text mining | PubMed |
| Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease. | Mol Neurodegener | 2020 | 32677986 | PubTator, text mining | PubMed |
| Wilson disease patient with rare heterozygous mutations in ATP7B accompanied by distinctive nocturnal enuresis: A case report. | Medicine (Baltimore) | 2020 | 32664103 | PubTator, text mining | PubMed |
| Treatment of Neuroblastoma Cells with Inhibitors of Protein Disulfide Isomerase Upregulates NQO1 Activity. | Chem Res Toxicol | 2020 | 32662633 | PubTator, text mining | PubMed |
| Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer. | Molecules | 2020 | 32660101 | PubTator, text mining | PubMed |
| Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs. | Cancers (Basel) | 2020 | 32650527 | PubTator, text mining | PubMed |
| Role of Curcumin and (-)-Epigallocatechin-3-O-Gallate in Bladder Cancer Treatment: A Review. | Cancers (Basel) | 2020 | 32635637 | PubTator, text mining | PubMed |
| Calcium Signaling Alterations Caused by Epigenetic Mechanisms in Pancreatic Cancer: From Early Markers to Prognostic Impact. | Cancers (Basel) | 2020 | 32629766 | PubTator, text mining | PubMed |
| Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early Detection. | Front Genet | 2020 | 32625237 | PubTator, text mining | PubMed |
| Glucocorticoid receptor complexes form cooperatively with the Hsp90 co-chaperones Pp5 and FKBPs. | Sci Rep | 2020 | 32612187 | PubTator, text mining | PubMed |
| Comparison of Biostimulant Treatments in Acmella oleracea Cultivation for Alkylamides Production. | Plants (Basel) | 2020 | 32610670 | PubTator, text mining | PubMed |
| Methylation-Based Therapies for Colorectal Cancer. | Cells | 2020 | 32599894 | PubTator, text mining | PubMed |
| Validated limited gene predictor for cervical cancer lymph node metastases. | Oncotarget | 2020 | 32595829 | PubTator, text mining | PubMed |
| Comprehensive Transcriptomic Analysis and Experimental Validation Identify lncRNA HOXA-AS2/miR-184/COL6A2 as the Critical ceRNA Regulation Involved in Low-Grade Glioma Recurrence. | Onco Targets Ther | 2020 | 32581558 | PubTator, text mining | PubMed |
| Biallelic MFSD2A variants associated with congenital microcephaly, developmental delay, and recognizable neuroimaging features. | Eur J Hum Genet | 2020 | 32572202 | PubTator, text mining | PubMed |
| Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome. | NPJ Breast Cancer | 2020 | 32566746 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7980/papers?page=48